Search by PDB author

Solution structure of extended PDZ2 domain from NHERF1 (150-270)
Descriptor:	Sodium/hydrogen exchange regulatory cofactor NHE-RF1
Authors:	Bhattacharya, S, Cowburn, D, Bu, Z.
Deposit date:	2009-05-27
Release date:	2009-12-29
Last modified:	2022-03-16
Method:	SOLUTION NMR
Cite:	A dynamic intramolecular conformational switch autoregulates the scaffolding protein NHERF1 To be Published

2KRG

Solution Structure of human sodium/ hydrogen exchange regulatory factor 1(150-358)
Descriptor:	Na(+)/H(+) exchange regulatory cofactor NHE-RF1
Authors:	Bhattacharya, S, Dai, Z, Li, J, Baxter, S, Callaway, D.J.E, Cowburn, D, Bu, Z.
Deposit date:	2009-12-17
Release date:	2009-12-29
Last modified:	2023-07-26
Method:	SOLUTION NMR
Cite:	A conformational switch in the scaffolding protein NHERF1 controls autoinhibition and complex formation. J.Biol.Chem., 285, 2010

4HDI

Crystal Structure of 3E5 IgG3 FAB from mus musculus
Descriptor:	Ig heavy chain V region RF, Ig gamma-3 chain C region, Kappa light chain variable region, ...
Authors:	Janda, A, Eryilmaz, E, Kim, J, Cordero, R.J.B, Cowburn, D, Casadevall, A.
Deposit date:	2012-10-02
Release date:	2013-04-17
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (2.449 Å)
Cite:	Global structures of IgG isotypes expressing identical variable regions. Mol.Immunol., 56, 2013

1AYC

CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
Descriptor:	PEPTIDE PDGFR-740, PROTEIN-TYROSINE PHOSPHATASE SYP (N-TERMINAL SH2 DOMAIN)
Authors:	Lee, C.-H, Kuriyan, J.
Deposit date:	1994-05-15
Release date:	1994-08-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (2.3 Å)
Cite:	Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure, 2, 1994

1AYA

CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
Descriptor:	PEPTIDE PDGFR-1009, PROTEIN-TYROSINE PHOSPHATASE SYP (N-TERMINAL SH2 DOMAIN)
Authors:	Lee, C.-H, Kuriyan, J.
Deposit date:	1994-05-15
Release date:	1994-08-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (2.05 Å)
Cite:	Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure, 2, 1994

1AYB

CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
Descriptor:	PEPTIDE IRS-1-895, PROTEIN-TYROSINE PHOSPHATASE SYP (N-TERMINAL SH2 DOMAIN)
Authors:	Lee, C.-H, Kuriyan, J.
Deposit date:	1994-05-15
Release date:	1994-08-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (3 Å)
Cite:	Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure, 2, 1994

1AYD

CRYSTAL STRUCTURES OF PEPTIDE COMPLEXES OF THE AMINO-TERMINAL SH2 DOMAIN OF THE SYP TYROSINE PHOSPHATASE
Descriptor:	PROTEIN-TYROSINE PHOSPHATASE SYP (N-TERMINAL SH2 DOMAIN)
Authors:	Lee, C.-H, Kuriyan, J.
Deposit date:	1994-05-15
Release date:	1994-08-31
Last modified:	2024-02-07
Method:	X-RAY DIFFRACTION (2.2 Å)
Cite:	Crystal structures of peptide complexes of the amino-terminal SH2 domain of the Syp tyrosine phosphatase. Structure, 2, 1994

1SHB

CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
Descriptor:	PHOSPHOPEPTIDE B, V-SRC SH2 DOMAIN
Authors:	Waksman, G, Kuriyan, J.
Deposit date:	1992-08-18
Release date:	1993-10-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (2 Å)
Cite:	Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature, 358, 1992

1SHA

CRYSTAL STRUCTURE OF THE PHOSPHOTYROSINE RECOGNITION DOMAIN SH2 OF V-SRC COMPLEXED WITH TYROSINE-PHOSPHORYLATED PEPTIDES
Descriptor:	PHOSPHOPEPTIDE A, V-SRC SH2 DOMAIN
Authors:	Waksman, G, Kuriyan, J.
Deposit date:	1992-08-18
Release date:	1993-10-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	Crystal structure of the phosphotyrosine recognition domain SH2 of v-src complexed with tyrosine-phosphorylated peptides. Nature, 358, 1992

1SPR

BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
Descriptor:	PHOSPHATE ION, SRC TYROSINE KINASE SH2 DOMAIN
Authors:	Waksman, G, Kuriyan, J.
Deposit date:	1993-03-05
Release date:	1994-05-31
Last modified:	2024-02-14
Method:	X-RAY DIFFRACTION (2.5 Å)
Cite:	Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell(Cambridge,Mass.), 72, 1993

1SPS

BINDING OF A HIGH AFFINITY PHOSPHOTYROSYL PEPTIDE TO THE SRC SH2 DOMAIN: CRYSTAL STRUCTURES OF THE COMPLEXED AND PEPTIDE-FREE FORMS
Descriptor:	PEPTIDE YEEI, SRC SH2 DOMAIN
Authors:	Waksman, G, Kuriyan, J.
Deposit date:	1993-03-05
Release date:	1994-05-31
Last modified:	2011-07-13
Method:	X-RAY DIFFRACTION (2.7 Å)
Cite:	Binding of a high affinity phosphotyrosyl peptide to the Src SH2 domain: crystal structures of the complexed and peptide-free forms. Cell(Cambridge,Mass.), 72, 1993

1CKB

STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
Descriptor:	C-CRK N-TERMINAL SH3 DOMAIN, SOS PEPTIDE (PRO-PRO-PRO-VAL-PRO-PRO-ARG-ARG-ARG-ARG)
Authors:	Wu, X, Kuriyan, J.
Deposit date:	1995-01-24
Release date:	1995-05-08
Last modified:	2024-02-07
Method:	X-RAY DIFFRACTION (1.9 Å)
Cite:	Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure, 3, 1995

1CKA

STRUCTURAL BASIS FOR THE SPECIFIC INTERACTION OF LYSINE-CONTAINING PROLINE-RICH PEPTIDES WITH THE N-TERMINAL SH3 DOMAIN OF C-CRK
Descriptor:	C-CRK N-TERMINAL SH3 DOMAIN, C3G PEPTIDE (PRO-PRO-PRO-ALA-LEU-PRO-PRO-LYS-LYS-ARG)
Authors:	Wu, X, Kuriyan, J.
Deposit date:	1995-01-24
Release date:	1995-05-08
Last modified:	2024-02-07
Method:	X-RAY DIFFRACTION (1.5 Å)
Cite:	Structural basis for the specific interaction of lysine-containing proline-rich peptides with the N-terminal SH3 domain of c-Crk. Structure, 3, 1995

1HCT

NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
Descriptor:	ACETYL-PYEEIE-OH, HUMAN SRC
Authors:	Gampe Junior, R.T, Xu, R.X.
Deposit date:	1994-09-02
Release date:	1995-09-15
Last modified:	2022-02-23
Method:	SOLUTION NMR
Cite:	Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry, 34, 1995

1HCS

NMR STRUCTURE OF THE HUMAN SRC SH2 DOMAIN COMPLEX
Descriptor:	ACETYL-PYEEIE-OH, HUMAN SRC
Authors:	Gampe Junior, R.T, Xu, R.X.
Deposit date:	1994-09-02
Release date:	1995-09-15
Last modified:	2022-02-23
Method:	SOLUTION NMR
Cite:	Solution structure of the human pp60c-src SH2 domain complexed with a phosphorylated tyrosine pentapeptide. Biochemistry, 34, 1995

1M30

Solution structure of N-terminal SH3 domain from oncogene protein c-Crk
Descriptor:	Proto-oncogene C-crk
Authors:	Schumann, F.H, Varadan, R, Tayakuniyil, P.P, Hall, J.B, Camarero, J.A, Fushman, D.
Deposit date:	2002-06-26
Release date:	2003-08-05
Last modified:	2021-10-27
Method:	SOLUTION NMR
Cite:	Changing protein backbone topology: Structural and dynamic consequences of the backbone cyclization in SH3 domain To be Published

1M3C

Solution structure of a circular form of the N-terminal SH3 domain (E132C, E133G, R191G mutant) from oncogene protein c-Crk
Descriptor:	Proto-oncogene C-crk
Authors:	Schumann, F.H, Varadan, R, Tayakuniyil, P.P, Hall, J.B, Camarero, J.A, Fushman, D.
Deposit date:	2002-06-27
Release date:	2003-08-05
Last modified:	2021-10-27
Method:	SOLUTION NMR
Cite:	Changing protein backbone topology: Structural and dynamic consequences of the backbone cyclization in SH3 domain To be Published

1M3B

Solution structure of a circular form of the N-terminal SH3 domain (A134C, E135G, R191G mutant) from oncogene protein c-Crk.
Descriptor:	Proto-oncogene C-crk
Authors:	Schumann, F.H, Varadan, R, Tayakuniyil, P.P, Hall, J.B, Camarero, J.A, Fushman, D.
Deposit date:	2002-06-27
Release date:	2003-08-05
Last modified:	2021-10-27
Method:	SOLUTION NMR
Cite:	Changing protein backbone topology: Structural and dynamic consequences of the backbone cyclization in SH3 domain To be Published

1M3A

Solution structure of a circular form of the truncated N-terminal SH3 domain from oncogene protein c-Crk.
Descriptor:	Proto-oncogene C-crk
Authors:	Schumann, F.H, Varadan, R, Tayakuniyil, P.P, Hall, J.B, Camarero, J.A, Fushman, D.
Deposit date:	2002-06-27
Release date:	2003-08-05
Last modified:	2021-10-27
Method:	SOLUTION NMR
Cite:	Changing protein backbone topology: Structural and dynamic consequences of the backbone cyclization in SH3 domain To be Published

1BKL

SELF-ASSOCIATED APO SRC SH2 DOMAIN
Descriptor:	PP60 V-SRC TYROSINE KINASE TRANSFORMING PROTEIN
Authors:	Holland, D.R, Rubin, J.R.
Deposit date:	1997-05-02
Release date:	1997-07-23
Last modified:	2023-08-02
Method:	X-RAY DIFFRACTION (2.1 Å)
Cite:	Novel Pp60Src Sh2 Domain Crystal Structures: A 2.0 Angstrom Co-Crystal Structure of a D-Amino Acid Substituted Phosphopeptide Complex and a 2.1 Angstrom Apo Structure Displaying Self-Association To be Published

4J99

Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659T Mutation.
Descriptor:	Fibroblast growth factor receptor 2, MAGNESIUM ION, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, ...
Authors:	Chen, H, Mohammadi, M.
Deposit date:	2013-02-15
Release date:	2013-08-07
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (1.8474 Å)
Cite:	Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. Cell Rep, 4, 2013

4J95

Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic K659N Mutation Responsible for an Unclassified Craniosynostosis Syndrome in Space Group C2.
Descriptor:	Fibroblast growth factor receptor 2, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, SULFATE ION
Authors:	Chen, H, Mohammadi, M.
Deposit date:	2013-02-15
Release date:	2013-08-07
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (2.3767 Å)
Cite:	Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. Cell Rep, 4, 2013

4J98

Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Gain-of-Function K659Q Mutation.
Descriptor:	Fibroblast growth factor receptor 2, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, SULFATE ION
Authors:	Huang, Z, Chen, H, Mohammadi, M.
Deposit date:	2013-02-15
Release date:	2013-08-07
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (2.3067 Å)
Cite:	Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. Cell Rep, 4, 2013

4J97

Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659E Mutation Identified in Endometrial Cancer.
Descriptor:	Fibroblast growth factor receptor 2, PHOSPHOMETHYLPHOSPHONIC ACID ADENYLATE ESTER, SULFATE ION
Authors:	Chen, H, Mohammadi, M.
Deposit date:	2013-02-15
Release date:	2013-08-07
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (2.5482 Å)
Cite:	Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. Cell Rep, 4, 2013

4J96

Crystal Structure of FGF Receptor 2 (FGFR2) Kinase Domain Harboring the Pathogenic Gain-of-Function K659M Mutation Identified in Cervical Cancer.
Descriptor:	CITRATE ANION, Fibroblast growth factor receptor 2, MAGNESIUM ION, ...
Authors:	Chen, H, Mohammadi, M.
Deposit date:	2013-02-15
Release date:	2013-08-07
Last modified:	2023-09-20
Method:	X-RAY DIFFRACTION (2.2972 Å)
Cite:	Cracking the Molecular Origin of Intrinsic Tyrosine Kinase Activity through Analysis of Pathogenic Gain-of-Function Mutations. Cell Rep, 4, 2013

<123 >

Total results:	54
Displayed results:	25
Sorted by:	Hit score (from highest)